Login
Toggle navigation
Videos
Categories
Trending
CEO Jessica Skon Highlights BTS Group's Record Quarter in Discussion with Equity Analyst Rikard Engberg | Jessica Skon - CEO of BTS group
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Jessica Skon is the President & CEO, BTS Group
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Heikki Haasmaa on the Importance of Diverse Perspectives in Designing Future Smart Cities | Heikki Haasmaa, CEO, Sitowise Group Oyj.
00:10:00
Deciphering the Market: Insights from Jeffrey Gundlach on Current Economic Signals | Jeffrey Gundlach, CEO , DoubleLine Capital.
00:10:00
Tom Lister of Permira on Strategic Sectors, Selling Strategy, and Investor Resilience | Tom Lister, Co-Managing Partner, Permira.
00:10:00
Interview with Stefano Achermann | Stefano Achermann, CEO, Be Think Solve Execute Sp ABET:MIL
00:10:00
Rashid's Journey: Transformative Impact of Technology on Education by 2030
00:10:00
Founders Metals: Progress, Discoveries, and Future Prospects in Guyana's Gold Exploration
00:10:00
Daniel Dines, CEO and Founder of UiPath, discusses the company's leadership in automation with Dave Vellante at UiPath.
00:10:00
CynergisTek: Leading Healthcare Cybersecurity with Mac McMillan, Founder and CEO | Mac McMillan, CEO and President of cynergistek inc
00:10:00
4D Medical Achieves Milestone: Generates First Clinical SAS Revenue and Explores International Expansion with Revolutionary Respiratory Imaging Technology| Dr Andreas Fouras, CEO, 4dmedical ltd.
00:10:00
I80 Gold CEO Euan Downey Discusses Market Trends and Company Strategy Amidst Industry Challenges
00:10:00
A Legacy of Resilience: From Family Roots to IPO Success in Brazil's Real Estate Sector | Leandro Melnick , CEO,Even Construtora e Incorporadora SA.
00:10:00
investing in companies that The firm typically wants 10% shareholding|Hampus Jakobsson,Co-founder and General Partner,Pale Blue Dot